Obesity Likely to Shorten Life by Nearly 10 Years for Americans - Applied Clinical Trials

ADVERTISEMENT

See our 2012 Buyers Guide Digital Edition.
Find Pharma Search Engine
Obesity Likely to Shorten Life by Nearly 10 Years for Americans


Obesity Likely to Shorten Life by Nearly 10 Years for Americans

PR Newswire

Research Published in the Journal, Obesity, Confirms Obesity-Mortality Tie

SILVER SPRING, Md., March 19, 2013 /PRNewswire-USNewswire/ -- Being obese is likely to shorten life by nearly 10 years for America's young and middle-aged adults, according to research published in the medical journal, Obesity. The article, "Obesity and Early Mortality in the U.S.," by James A. Greenberg, PhD, Associate Professor, Department of Health and Nutrition Sciences at Brooklyn College of the City University of New York, shows mortality is likely to occur 9.44 years earlier for study participants who were obese (BMI≥30). Further, Greenberg's study also made estimates for overweight (25 to <30kg/m2) individuals, and those with grade 1 obesity (BMI, 30 to <35) and grade 2-3 obesity (BMI, ≥35). Mortality was likely to occur earlier in these categories as well by 4.4, 6.7 and 14.2 years, respectively. The study's estimates apply to nonsmoking young and middle-aged adults without pre-existing serious illness who constitute about one third of American adults.

(Logo: http://photos.prnewswire.com/prnh/20120531/DC16753LOGO)

"While obesity is a serious health problem, there are few reliable measures of its health hazards in the U.S.," said Greenberg. "My objective was to estimate how much earlier mortality is likely to occur for Americans who are overweight or obese, with the end goal of improving awareness of the impact that excess weight has on longevity."

Using data from 37,632 participants in three National Health and Nutrition Examination Surveys (NHANES), Greenberg calculated the relative risk of death from all causes and number of years of life lost. All estimates were adjusted for demographic and lifestyle factors. The study also explored the effects of pre-existing illness, smoking, and older age on the number of years lost. The sample population is nationally representative of the United States.

Greenberg's findings confirm a large body of research that shows excess weight and obesity leads to higher morbidity and earlier death. Another recent large study, "Body-mass index and mortality among 1.46 million white adults," by Amy Berrington de Gonzalez et al. in the New England Journal of Medicine, confirms these findings.

"Experts agree the relationship between obesity and mortality is a complicated one," said Harvey Grill, PhD, President of The Obesity Society (TOS). "However, it's clear from a vast body of research that obesity and mortality are associated, and that a higher BMI is tied to earlier death as well as higher rates of disease, many of which are serious."

Less clear is the effect of individual factors and the length of follow-up of participants in studies on obesity and mortality. TOS encourages continued work by researchers to identify ways to improve the investigation into the relationship between obesity and mortality.

About The Obesity Society
The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. TOS is committed to encouraging research on the causes, treatment, and prevention of obesity as well as to keeping the scientific community and public informed of new advances in the field. For more information, please visit www.obesity.org .  

SOURCE The Obesity Society

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

FindPharma
Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
94%
Borrow lightly from EMA's pathway program?
0%
Create entirely its own pathway program?
6%
View Results
Untitled Document

Click here